Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX07 Triprolidine
D01782 Triprolidine hydrochloride (USP)
Classification of Japanese OTC drugs [BR:br08313]
Agents for otolaryngologic use
69 Oral medicine for nasal inflammation
D01782 Triprolidine hydrochloride (USP)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Triprolidine
D01782 Triprolidine hydrochloride (USP)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01111 Triprolidine
D01782 Triprolidine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D01782 Triprolidine hydrochloride (USP)
Rx-to-OTC switch list in the USA [br08315.html]
D01782
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01111 Triprolidine
Other DBs
CAS:
6138-79-0
PubChem:
7848844
ChEBI:
32265
LigandBox:
D01782
NIKKAJI:
J1.591.795D
KCF data
ATOM 23
1 X Cl 29.7575 -15.7912
2 C2b C 23.9165 -17.9663
3 C1b C 22.7028 -17.2667
4 N1y N 22.7018 -15.8660
5 C1x C 21.5661 -15.0520
6 C1x C 21.9980 -13.7193
7 C1x C 23.3986 -13.7185
8 C1x C 23.8326 -15.0503
9 C8x C 20.2769 -20.0664
10 C8y C 20.2769 -21.4672
11 C8x C 21.4929 -22.1676
12 C8x C 22.7018 -21.4672
13 C8y C 22.7018 -20.0664
14 C8x C 21.4929 -19.3660
15 C2c C 23.9153 -19.3671
16 C8y C 25.1280 -20.0683
17 C8x C 25.1213 -21.4670
18 C8x C 26.3340 -22.1684
19 C8x C 27.5477 -21.4689
20 C8x C 27.5487 -20.0681
21 N5x N 26.3360 -19.3669
22 C1a C 19.0641 -22.1683
23 O0 O 30.1596 -17.6328
BOND 23
1 4 5 1
2 9 10 2
3 10 11 1
4 11 12 2
5 12 13 1
6 13 14 2
7 14 9 1
8 5 6 1
9 13 15 1
10 6 7 1
11 15 16 1
12 7 8 1
13 8 4 1
14 3 4 1
15 16 17 2
16 17 18 1
17 18 19 2
18 19 20 1
19 20 21 2
20 21 16 1
21 2 3 1
22 10 22 1
23 15 2 2